April 1988
Advocate;4/12/88, Issue 496, Special Section p9
Reports that the Philip Mendelker AIDS Prevention Clinic is providing medical evaluation, health education and AIDS information at the Gay and Lesbian Community Services Center in Los Angeles, California.


Related Articles

  • AIDS vaccine.  // Newsweek (Atlantic Edition);06/15/98 (Atlantic Edition), Vol. 131 Issue 24, p3 

    Notes the June 1998 approval by the United States Food and Drug Administration of a large-scale efficacy trial of an AIDS vaccine. Development of Aidsvax by the San Francisco, California company Vaxgen; Extent of the trial.

  • Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe. van der Straten, Ariane; Helen Cheng; Minnis, Alexandra M. // Journal of the International AIDS Society;2010, Vol. 13 Issue 1, p1 

    Background: We examined the use of male condoms and the diaphragm following completion of a clinical trial of the diaphragm's HIV prevention effectiveness. In the trial, called Methods for Improving Reproductive Health in Africa (MIRA), women were randomized to a diaphragm group (diaphragm, gel...

  • Assessing HIV/AIDS Stigma and Discrimination in Developing Countries. Genberg, Becky; Kawichai, Surinda; Chingono, Alfred; Sendah, Memory; Chariyalertsak, Suwat; Konda, Kelika; Celentano, David // AIDS & Behavior;Sep2008, Vol. 12 Issue 5, p772 

    HIV/AIDS-related stigma and discrimination are barriers to HIV prevention effectiveness, voluntary counseling and testing uptake, and accessing care in many international settings. Most published stigma scales are not comprehensive and have been primarily tested in developed countries. We sought...

  • Multiple opportunistic AIDS-associated disorders strictly related to immunodeficiency levels, in a girl with congenital HIV infection. Manfredi, Roberto; Calza, Leonardo; Chiodo, Francesco // International Journal of STD & AIDS;Sep2003, Vol. 14 Issue 9, p638 

    A 16-year-old girl with vertical HIV disease treated since birth suffered from six different AIDS-defining disorders until now. Even during the highly active antiretroviral therapy, multiple AIDS-related opportunistic infections may complicate the course of long-term congenital HIV disease,...

  • NY leads search for AIDS vaccine. Scott, Gale // Crain's New York Business;8/21/2006, Vol. 22 Issue 34, p1 

    This article reports that clinical trials of several AIDS vaccines, including Merck & Co. Inc.'s AD-5 vaccine, are continuing at many major medical institutions in Manhattan, New York City. According to Beryl Koblin, head of the Laboratory of Infectious Disease Prevention for the New York Blood...

  • Ethical Challenges in Efficacy Trials of Vaginal Microbicides for HIV Prevention. De Zoysa, Isabelle; Elias, Christopher J.; Bentley, Margaret E. // American Journal of Public Health;Apr98, Vol. 88 Issue 4, p571 

    This paper discusses some of the ethical challenges raised by advanced clinical trials designed to assess the safety and efficacy of vaginal microbicides in protecting women from HIV infection. The ethical principles that guide clinical research involving human subjects require that all...

  • A Fail-Safe Strategy: When in Doubt, Conduct the Trial.  // American Journal of Public Health;Jun2003, Vol. 93 Issue 6, p876 

    The article discusses the benefits of conducting trials for the AIDSVAX vaccine against AIDS. The rationale behind the 1994 decision to abandon a federally funded trial of AIDSVAX and the decision of the National Institutes of Health in 2002 not to proceed with phase III trials among U.S. men...

  • Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions. Minnis, A. M.; Padian, N. S. // Sexually Transmitted Infections;Jun2005, Vol. 81 Issue 3, p193 

    Objectives: To evaluate evidence for the effectiveness of female controlled physical and chemical barrier methods in preventing STI/HIV transmission, to examine recent reviews on microbicide development, and to highlight promising research directions. To discuss challenges in conducting...

  • First New Class Of HIV Drugs in 10 Years. Karlin, Susan // Discover;Jan2008, Vol. 29 Issue 1, p44 

    The article discusses HIV/AIDS prevention and treatment research conducted in 2007. An overview is provided of successes and setbacks in the medical field, citing the development of entry inhibitors and the efforts of pharmaceutical companies Merck and Pfizer. The remaining high cost of the...

  • Associations between depressive symptoms, sexual behaviour and relationship characteristics: a prospective cohort study of young women and men in the Eastern Cape, South Africa. Nduna, Mzikazi; Jewkes, Rachel K.; Dunkle, Kristin L.; Jama Shai, Nwabisa P.; Colman, Ian // Journal of the International AIDS Society;2010, Vol. 13 Issue 1, p1 

    Background: Psychological factors are often neglected in HIV research, although psychological distress is common in low- to middle-income countries, such as South Africa. There is a need to deepen our understanding of the role of mental health factors in the HIV epidemic. We set out to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics